Introduction
In the United States, 16,000,000 people have COPD, with 120,000 deaths annually, making it the fourth highest cause of death. 1 Many patients with COPD experience acute or chronic respiratory failure and may require prolonged respiratory care and mechanical ventilation through endotracheal or tracheostomy tubes. 2 Although the most common indication for tracheostomy is upper-airway ob-struction, 3 this procedure is usually suggested if intubation is planned to last longer than several weeks. 2 In contrast to endotracheal tubes, tracheostomy tubes are shorter, have a removable inner cannula for cleaning, and may have an open fenestration that can allow breathing through the upper airway or a closed fenestration to provide secure mechanical ventilatory support. 4 It has been speculated that the use of tracheostomies reduces dead space 2 and airway resistance and improves secretion clearance. 5 
SEE THE RELATED EDITORIAL ON PAGE 1365
Patients with COPD are commonly treated with shortacting bronchodilators and anticholinergic drugs via a nebulizer. A gas-powered jet nebulizer is often used to deliver aerosolized medications. The aerosol reaches patients' airways through a mouthpiece or an aerosol mask, and no significant difference in clinical response has been found between both interfaces. 6 Piccuito and Hess 7 reported that albuterol aerosol delivery at high gas flow was inefficient. They concluded that the use of a T-piece resulted in greater albuterol delivery compared with a tracheostomy collar (P ϭ .001). The most efficient nebulizer technique was with the T-piece using no additional flow (P Ͻ .001). More recently, Ari et al 8 reported greater deposition of albuterol through a tracheostomy tube from a jet nebulizer via a T-piece (13.9 Ϯ 2.6%) versus a tracheostomy collar (6.9 Ϯ 0.8%, P Ͻ .05). Moreover, aerosol therapy can be easily delivered through a tracheostomy tube, but is affected by humidification, gas flow, and type of interface used during aerosol therapy. 1, 7 According to a study by Lin et al 9 the face mask design affected the inhaled mass delivered. They found that when the mask was separated farther from the face, the inhaled mass was significantly reduced. 9 No studies were found on aerosol delivery with a tracheostomy collar or Wright mask or comparing those devices with an aerosol mask. Patients with tracheostomies have 3 options for inhaled aerosols: (1) plugging a tracheostomy tube with an open fenestration to use an aerosol mask, (2) a tracheostomy collar or tracheostomy tube with an open or closed fenestration, or (3) combination of aerosol mask and tracheostomy collar with an open fenestration such as with the Wright mask.
The Wright mask was recently developed and combines an aerosol mask to cover the nose and mouth with a tracheostomy collar for delivery of humidification with bland aerosol and oxygen for patients with tracheostomies. Although a literature search revealed no peer-reviewed published reports on Wright mask performance, an abstract by Carvalho et al 10 evaluated the efficacy and feasibility of the Wright mask for delivery of oxygen and humidity to subjects with tracheostomies. The authors reported no differences in blood oxygen saturation, comfort, ease of use, or ease of breathing in subjects who used the Wright mask compared with both the tracheostomy collar and aerosol mask. This suggested comparable delivery of oxygen and humidity by the 3 devices. Because of its unique design combining a tracheostomy collar and aerosol mask, the initial expectation for the Wright mask was that there would be greater deposition, especially compared with the tracheostomy collar and aerosol mask interfaces.
The primary purpose of this study was to quantify the inhaled dose of aerosolized medication deposited distal to the trachea using different interfaces (tracheostomy collar, Wright mask, and aerosol mask) in an adult tracheostomy model and to assess the impact of use of a tracheostomy collar with an uncuffed tracheostomy tube with a closed or open fenestration. Upon review of the literature, 3 research questions arose: (1) What is the impact of different interfaces on albuterol delivery using an uncuffed tracheostomy tube with an open fenestration port? (2) How much albuterol is delivered using a tracheostomy collar when the fenestration port is open or closed? (3) What is the effect of the inspiratory-expiratory ratio (I:E) on aerosol delivery in simulated spontaneously breathing adult models with a tracheostomy?
Methods

Experimental Setup
An anatomic teaching mannequin (Medical Plastic Laboratory, Gatesville, Texas) with a tracheostomy opening was adapted so that the mannequin's bronchi were connected via a Y-adapter to a collecting filter (303 Respirgard II, Vital Signs, Englewood, Colorado), which was
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Current knowledge
Aerosol therapy is a common treatment in patients with chronic respiratory disease. Following tracheostomy, the optimum method for aerosol delivery has not been clearly identified. Choice of interface, breathing pattern, and the presence of humidity may all play a role in the efficiency of aerosol delivery.
What this paper contributes to our knowledge
A tracheostomy collar was the best device for delivering aerosol therapy compared with Wright and aerosol masks in a model of the respiratory system. An inspiratory-expiratory ratio (I:E) of 2:1 resulted in greater aerosol deposition compared with an I:E of 1:2. Aerosol deposition was improved when the fenestration port was closed while using the tracheostomy collar.
connected through a corrugated tube to a breathing simulator (dual-phase control respirator pump, Harvard Apparatus, Holliston, Massachusetts) (Fig. 1) . The breathing simulator with a sinusoidal pattern was set to adult parameters of 20 breaths/min with a tidal volume of 400 mL 7 at I:E of 1:2 and 2:1.
Tracheostomy Tube
An 8-mm adult fenestrated tracheostomy tube (Shiley, Mallinckrodt, Boulder, Colorado) was placed into the mannequin's stoma. The cuff was always deflated. All experiments were run at I:E of 1:2 and 2:1.
Nebulizer and Flow
A jet nebulizer (eValueMed, Tri-anim, Sylmar, California) with a reported mass median aerodynamic diameter of 2.3 m and geometric SD of 2.1 was filled with 2.5 mg/ 3 mL (0.083%) albuterol sulfate aqueous solution (Dey Pharma, Napa, California). The nebulizer was controlled by a backpressure-compensated flow meter (Soft-Touch Timeter 15001, Allied Healthcare Products, St Louis, Missouri) at 8 L/min with 100% oxygen. At a 1:2 ratio, the inspiratory flow rate was 24 L/min. At a 2:1 ratio, the inspiratory flow rate was 12 L/min. Flow was discontinued at the end of nebulization.
Interfaces
Aerosol was delivered from the nebulizer through a tracheostomy collar (Airlife, Cardinal Health, Dublin, Ohio), a Wright mask (Wright Solutions, Marathon, Florida), or a standard aerosol mask (Airlife, Cardinal Health) (Fig. 2) . The Wright and aerosol masks were tested with an open fenestration. The tracheostomy collar was tested with open and closed fenestrations.
Assay Technique
On completion of each experiment, the filters were removed from the experimental setup, labeled, and capped. Drug was eluted with 10 mL of 0.1% normal hydrochloric acid with gentle agitation for 3 min. The drug content was quantified using a spectrophotometer (DC 500 series, Beckman Instruments, Fullerton, California) at a wavelength of 276 nm using a 1-mL quartz cuvette. Each interface was tested in triplicate.
Data Analysis
The amount of aerosol deposited on the filter was quantified and expressed as a percentage of the nominal dose loaded into the nebulizer. Descriptive statistics, including the mean Ϯ SD, were calculated for each condition tested. Paired t tests were conducted to evaluate differences in the mean inhaled percent of dose delivered by the jet nebulizer at 2 I:E ratios. One-way analysis of variance and the Scheffé post hoc multiple-comparison test were used to determine differences among the means for the conditions tested. Repeated-measures one-way analysis of variance and pairwise comparison were performed to determine differences among the means between open versus closed fenestration. All data analysis was performed using SPSS 18.0 (SPSS, Chicago, Illinois), and statistical significance was defined as P Ͻ .05. The predictive analytics software PASW 18.0 (SPSS) was used to control data analysis.
Results
The percent albuterol dose delivered distal to the bronchi of the adult model is shown in Table 1 .
Delivery by Interface
Delivery of Albuterol was greater with the tracheostomy collar at both I:E of 1:2 and 2:1 (7.0 Ϯ 0.80% and 11.6 Ϯ 1.4, respectively) compared with the Wright mask (4.1 Ϯ 0.6% and 7.2 Ϯ 0.6%, respectively) and aerosol mask (3.5 Ϯ 0.04% and 6.1 Ϯ 0.5%, respectively) and the lowest deposition was with the aerosol mask.
Delivery by I:E
In experiments with an open fenestration, the mean deposition was significantly higher at an I:E of 2:1 versus 1:2 (P ϭ .009 for the tracheostomy collar, P ϭ .02 for the Wright mask, P ϭ .01 for the aerosol mask). The I:E and aerosol delivery were directly related. A longer inspiratory time leads to a greater amount of aerosol deposited. In the closed fenestration experiments, the trend toward higher deposition with an I:E of 2:1 versus 1:2 was not significant (P ϭ .18).
Delivery by Fenestration
Although deposition trended higher with closed versus open fenestration, differences were not significant (P Ͼ .05).
Discussion
Role of Upper Airways in Aerosol Loss
We found greater aerosol deposition at the collecting filter when aerosol passed through the tracheostomy tube rather than the simulated upper airway. The upper airways (nose and laryngeal and branching regions) act as an important pulmonary defense mechanism because they provide an extremely efficient aerodynamic filter that prevents larger particle sizes from depositing deeply into the lower airways. 11 Therefore, nasal and oral breathing imply higher resistance 12 and greater filtering of aerosol particles as demonstrated with both the Wright and aerosol masks. Aerosol loss in the nasopharynx is higher with a face mask than with a mouthpiece. 13 Everard et al 14 found that there was considerable intersubject variation in the ability of the upper airways to filter out particles when inhaled through either the oral or nasal airway. Aerosol loss during transport from upper airways to deep into the lungs is an important factor in nebulizer therapy. 15 Other factors such as mask seal 16 and mask efficiency 17 may play a large role in aerosol delivery. In addition, aerosol generated during exhalation may not reach the lungs at all, whereas large droplets that reach the airway may be deposited in the upper airways such as the naso/oropharynx and hypopharynx. Therefore, only very small droplets may enter the lungs and then be exhaled. 13 In contrast, Usmani et al 18 addressed drug particle sizes of albuterol in subjects with obstructive lung disease (asthma), showing clear differences in lung and regional deposition, as well as aerosol losses during exhalation. Although smaller (1.5 m) particles had greater peripheral deposition than either 3.0-or 6.0-m particles, the larger albuterol particles produced greater bronchodilator response.
The volumes of the upper airway also play a role in lung delivery of aerosols. Much of the aerosol entering the upper airway at the end of inspiration is exhaled before reaching the lower airways. A lower upper-airway volume results in a greater proportion of aerosol in the gas volume 4 stated that tracheostomy tubes can decrease dead space by up to 100 mL compared with a spontaneously breathing subject. The internal volume and related anatomic dead space of a 7.5-mm inner diameter tracheostomy tube are between 5 and 6 mL. 2 In contrast, one study in cadavers determined the anatomic dead space of the extrathoracic airways (not including the trachea and main bronchi) to be ϳ75 mL. 19 With a tidal volume of 400 mL, the 70 mL lost in the upper airway would reduce the inhaled dose by a calculated 17.5%. This rationale seems to agree with our findings of reduced lung dose with the Wright and aerosol masks, which require transit through the upper airway.
Effect of Interfaces
The amount of albuterol delivered distal to the trachea was significantly lower with both the aerosol and Wright masks compared with the tracheostomy collar. This was presumably the result of aerosol wasted in the air and in the upper airways above the stoma. When using the Wright and aerosol masks, aerosol travels through the nose, mouth, and extrathoracic airways, which causes part of the aerosol delivered to be deposited in the upper airways before it reaches the collecting filter, thus reducing the effectiveness of aerosol delivery. Moreover, using a tracheostomy collar caused aerosol particles to travel shorter distances to reach the collecting filter compared with the Wright and aerosol masks.
The results of our study correspond with those of Carvalho et al, 10 who evaluated the feasibility of the Wright mask and its efficacy with humidity. They concluded that there were no large differences in blood oxygen saturation, comfort, ease of use, or ease of breathing with the Wright mask compared with the tracheostomy collar and aerosol mask.
The results obtained with the tracheostomy collar and a closed fenestration at an I:E of 1:2 (9.4 Ϯ 1.5%) were different from those of Piccuito and Hess 7 using the same I:E with a tracheostomy collar and non-fenestrated tracheostomy tube (12.9 Ϯ 1.3%). The difference between the results may stem from differences in the experimental models. They used a semicircular model that simulated a patient's neck. Also, the capture filter was attached between the lung model and the distal end of the tracheostomy tube. However, in our study, the mannequin's bronchi were connected via a Y-adapter to a collecting filter. Furthermore, in our study, the cuff was deflated at all times, allowing some aerosol particles to deposit in the upper airways.
Effect of I:E
Our findings suggest that the I:E substantially impacts the delivered dose. This observation was anticipated with use of continuous output aerosol generators, as aerosol that is not inhaled is typically wasted in the atmosphere. An I:E of 2:1 allows for 33% more of the generated aerosol to be inhaled compared with an I:E of 1:2. The difference in the deposited amount between these I:E ratios can be explained by the breathing pattern and the respiratory phase in which the medication was delivered. The inspiratory time was longer at an I:E of 2:1 compared with 1:2, allowing more time to inhale the aerosolized drug, thus causing more albuterol delivery to the simulated lung. In all open fenestration experiments, the amount of aerosolized albuterol deposited was affected significantly by the I:E. These findings suggest that a longer inspiratory time and a shorter time between inspirations lead to inhalation of a greater proportion of the emitted dose.
These results corroborate the findings of Hess et al, 20 who found that a longer inspiratory time increased the amount of albuterol aerosol delivered by a nebulizer (P Ͻ .001). Also, our results agree with those of Cameron et al, 21 who reported that lung deposition of a released aerosol was decreased markedly by reducing aerosol residence time (I:E). The results of our study may be in contrast to those of Lim et al, 22 who found that increasing the I:E by adding a breath-hold improved gas exchange during partial liquid ventilation. Oxygenation during partial liquid ventilation was affected by the I:E to a greater extent than during gas ventilation. Moreover, Gottschalk et al 23 found that an additional 14 -17% of the aerosol dose in the lungs was associated with deep inhalation and breathholding. However, these researchers evaluated the impact of breath-holding a bolus of aerosol, so the results show improvements with a single breath. In the case of continuous aerosol generation, a longer breath-hold leads to a greater proportion of emitted aerosol lost to the atmosphere that cannot be inhaled. The impact of breath-holding cannot be assessed with this model; however, it is less likely that inspiratory pause or breath-hold would increase total lung dose during slow inspiration with shorter times between inspirations.
Effect of Fenestration
In this study, albuterol delivery using a tracheostomy collar with a closed fenestration was greater compared with an open fenestration. The difference in the deposited amount between open and closed fenestrations may be explained by the dilution of air being drawn through the open fenestration from the upper airway. This means that less of the 400-mL tidal volume was drawn from the aerosol interface, so a smaller proportion of inhaled gas contained aerosol. In contrast, with a closed fenestration, the only source of inhaled gas was from the tracheostomy, and a higher proportion of the inhaled gas contained aerosol.
We had anticipated that the open fenestration would allow a more direct path of inhaled aerosol from the upper airways to the lungs and that the closed fenestration would make the tracheostomy tube an obstruction to inhaled aerosol by the mouth or nose. However, that variable was beyond the scope of this evaluation.
Clinical Implications
Based on this study, 3 insights may be given to clinicians to achieve a better outcome when administering aerosolized medications. First, a tracheostomy collar delivers more aerosol than either the aerosol or Wright mask, even when there is no open fenestration. Second, when delivering aerosol via a tracheostomy collar, close the fenestration hole during aerosol administration. Third, be aware that I:E impacts aerosol delivery, and instructing the patient to inhale the aerosolized medication slowly with a shorter expiratory time between inspirations may increase the delivered dose.
Limitations
This experiment was an in vitro bench study; therefore, the results should be subjected to clinical validation. Different breathing patterns may be seen in vivo. In addition, a homogeneous breathing simulator was used. Human subjects would show heterogeneous breathing patterns and different lung conditions. We did not study the effect of different breathing patterns, and the parameters were the same in all experiments. This study was conducted with only one type and size of tracheostomy tube. It is also important to note that the Wright mask was manufactured for humidification therapy via the nose, mouth, and trachea, not for aerosol drug therapy.
Future Studies
The effect of changing the respiratory setting should be explored to determine how aerosol delivery would be affected with different patient conditions, diseases, and ventilatory settings. Different I:E ratios should be explored further to help patients relieve their symptoms and to provide guidance to clinicians in administering aerosol therapy. In addition, different types and sizes of tracheostomy tubes should be studied to help other patients with varying equipment, such as pediatric tracheostomy tubes. Finally, clinical studies showing differences in outcome are required to fully vet the implications of this bench study.
Conclusions
This study demonstrated that a tracheostomy collar is the best device for delivering aerosol therapy compared with Wright and aerosol masks. An I:E of 2:1 lead to greater albuterol delivery compared with an I:E of 1:2. Albuterol delivery was better when the fenestration port was closed compared with open while using the tracheostomy collar.
